AngioDynamics, Inc.
General ticker "ANGO" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $481.9M (TTM average)
AngioDynamics, Inc. follows the US Stock Market performance with the rate: 44.0%.
Estimated limits based on current volatility of 5.3%: low 10.33$, high 11.50$
Factors to consider:
- Total employees count: 632 (-6.4%) as of 2026
- US accounted for 29.7% of revenue in the fiscal year ended 2024-05-31
- Top business risk factors: Market competition, Technological changes, Product acceptance, Regulatory and compliance, Acquisition/divestiture risks
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-05-31 to 2028-05-30
- 2026-05-31 to 2027-05-31 estimated range: [7.89$, 14.41$]
- 2027-05-31 to 2028-05-30 estimated range: [8.06$, 14.69$]
Financial Metrics affecting the ANGO estimates:
- Positive: with PPE of -30.2 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of 0.63 <= 2.37
- Positive: -13.52 < Operating profit margin, % of -11.09
- Negative: negative Net income
- Negative: 58.56 < Shareholder equity ratio, % of 63.94 <= 69.38
- Negative: -0.33 < Industry inventory ratio change (median), % of -0.14
- Negative: Investing cash flow per share per price, % of -1.22 <= -0.14
- Negative: negative Industry operating income (median)
- Negative: 0 < Interest expense per share per price, % of 0.06
Short-term ANGO quotes
Long-term ANGO plot with estimates
Financial data
| YTD | 2024-05-31 | 2025-05-31 | 2026-05-31 |
|---|---|---|---|
| Operating Revenue | $303.91MM | $292.50MM | $320.17MM |
| Operating Expenses | $496.35MM | $332.45MM | $360.10MM |
| Operating Income | $-192.44MM | $-39.95MM | $-39.93MM |
| Non-Operating Income | $0.80MM | $5.92MM | $3.63MM |
| Interest Expense | $0.00MM | $0.00MM | $0.30MM |
| R&D Expense | $31.51MM | $26.22MM | $29.45MM |
| Income(Loss) | $-191.64MM | $-34.03MM | $-36.30MM |
| Taxes | $-7.29MM | $-0.04MM | $0.44MM |
| Net Income(Loss)* | $-184.35MM | $-33.99MM | $-36.74MM |
| Stockholders Equity | $205.59MM | $182.97MM | $170.82MM |
| Inventory | $60.62MM | $62.01MM | $52.44MM |
| Assets | $317.67MM | $280.14MM | $267.16MM |
| Operating Cash Flow | $-28.16MM | $-10.13MM | $3.09MM |
| Capital expenditure | $5.77MM | $4.46MM | $2.58MM |
| Investing Cash Flow | $123.72MM | $-10.18MM | $-5.95MM |
| Financing Cash Flow | $-64.25MM | $-0.26MM | $0.56MM |
| Earnings Per Share** | $-4.59 | $-0.83 | $-0.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.